Bisphosphonate-associated osteonecrosis of the jaw: a review of 35 cases and an evaluation of its frequency in multiple myeloma patientsSamantha Pozzi, On behalf of the Gruppo Italiano St, Chiara Broglia et al.|Leukemia & lymphoma/Leukemia and lymphoma|2006Cited by 93
A randomized trial with melphalan and prednisone versus melphalan and prednisone plus thalidomide in newly diagnosed multiple myeloma patients not eligible for autologous stem cell transplantStefano Sacchi, Luciano Masini, Raffaella Marcheselli et al.|Leukemia & lymphoma/Leukemia and lymphoma|2011Cited by 28
Analysis of Frequency and Risk Factors for Developing Bisphosphonate Associated Osteonecrosis of the Jaw.Samantha Pozzi, Giuseppe Pollastri, Raffaella Marcheselli et al.|Blood|2005Cited by 26
Bisphosphonates associated osteonecrosis of the jaw: A long‐term follow‐up of a series of 35 cases observed by GISL and evaluation of its frequency over timeSamantha Pozzi, Luca Baldini, Raffaella Marcheselli et al.|American Journal of Hematology|2009Cited by 12
A RANDOMIZED PHASE II STUDY (GISL-MM03 TRIAL) WITH ORAL MELPHALAN plus PREDNISONE (MP) VERSUS MELPHALAN, plus PREDNISONE plus THALIDOMIDE (MPT) FOR NEWLY DIAGNOSED ELDERLY PATIENTS WITH MULTIPLE MYELOMAStefano Sacchi, Maura Brugiatelli, Raffaella Marcheselli et al.|IRIS UNIMORE (University of Modena and Reggio Emilia)|2009Cited by 1